Like us on Facebook!

Judy Barron Clinical Trials Experience

Her multi-specialty background training include coordinating the following clinical trials,

A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of XXXX Compared With Placebo and YYYY in Subjects With Moderate to Severe Plaque Psoriasis. 2012 – 2013.

A 12-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of XXXX to XXXX and Placebo in Patients with Moderate to Severe Plaque Psoriasis with a Long-Term Extension Period. 2012 – 2013.

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled,  2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of XXXX and XXX Vehicle Gel in the Treatment of Acne Vulgaris. 2012 – 2013.

A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multi-Center Study Comparing Generic  XXXX gel,  to Reference Listed Drug in the Treatment of Tinea  Pedis. 2012 – 2013.

A Phase 3 randomized, double-blind, 12-week vehicle controlled, parallel-group study assessing the efficacy and safety of XXXX cream versus vehicle cream in subjects with papulopustular rosacea, followed by a 40-week investigator-blinded extension comparing the long-term safety of XXXX cream versus YYYY gel. 2012 – 2013.

A randomized, double-blind, parallel-group, vehicle-controlled, multicenter study comparing XXXX cream to reference listed drug in the treatment of actinic keratoses of the face and balding scalp. 2012 – 2013.

A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Dose Escalating study to evaluate the safety and efficacy of XXXX cream applied once or twice-daily for 12 weeks in subjects with facial acne vulgaris. 2012.

A phase 2 study comparing treatment with XXXX with betamethasone Dipropionate in XXXX vehicle and calcipotriol in XXXX vehicle in subjects with psoriasis vulgaris. A multicenter, prospective, randomized double blind, 3-arm, parallel group, 4-week study in subjects with psoriasis vulgaris. 2012.

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare XXXX to YYYY Topical Gel, and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris. 2012.

A Sequential Treatment Regimen of Cryotherapy and XXXX gel, Compared to Cryotherapy Alone for the Treatment of Actinic Keratosis on the Face and Scalp. 2012.

A phase 2 study comparing treatment with XXXX with calcipitriol plus betamethasone ointment, XXXX vehicle and ointment vehicle in subjects with psoriasis vulgaris. A multicenter, prospective, randomized, investigator blinded, 4-arm, parallel group, 4-week study in subjects with psoriasis vulgaris. 2012.

A Phase III, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients with Mild to Moderate Active Ulcerative Colitis 2013

A Phase III, Double- Blind, Multi-Center, Placebo-Controlled Maintenance Trial of HMPL 004 in Subjects with Mild- Moderate Ulcerative Colitis with Clinical Remission or Response from Induction Therapy (NATRUL-4) 2013

A Double- Blind, Randomized, Placebo-controlled, Phase 3 Trial in Patients with Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of  Elobixibat 5mg and 10 mg for 26 weeks. 000079 ECHO 1.  2013

A multicenter, Open-Label, Safety and Tolerability Extension Trial of 5 mg and 10 mg Elobixibat Daily in the Treatment of Chronic Idiopathic Constipation. 000081 ECHO 3. 2013.

A Study to Assess the Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in subjects with Irritable Bowel Syndrome with Diarrhea (IBS-D)

A Randomized, Double-Blind, Placebo- Controlled, Dose- Ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Disperson (SSD) Tablets for the Prevention of Complications in Subjects with Early Decompensated Liver Cirrhosis. 2013.

A Randomized, 12 Week, Double Bind, Placebo- Controlled, Dose Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation ( IBS-C) 2013

A Randomized, Double- Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of  Patients with Diarrhea- Predominant Irritable Bowel Syndrome. Study 27018966IBS3002. 2013

A Randomized, Double- Blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea- Predominant Irritable Bowel Syndrome. Study 27018966IBS3001. 2013

A Randomized, 12 Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0) in Patients with Chronic Idiopathic Constipation (CIC3).

 

Share This: